Oct 28HHS draft policy lets licensed pharmacies compound six peptides, including BPC-157. What changed and what did not.
Skip to content
PeptideAgent

Clinics in Wyoming

By the PeptideAgent Editorial Team. Editorially reviewed, not clinically reviewed.  Last verified

What Wyoming law means for peptide clinics: who may prescribe, whether pharmacies may compound GLP-1 drugs (limited), how to check a clinic, and listings with their verification status.

Wyoming at a glance

503A framework
Follows the federal 503A framework
Telehealth prescribing
Regulatory: Telehealth allowed
Asynchronous prescribing
Regulatory: Async unclear
Compounded GLP-1 access
Regulatory: Compounded GLP-1 limited

Clinics serving Wyoming

No verified clinics serving Wyoming are listed yet. A provider appears here only after it passes the verification checklist, and those checks are still under way.

Looking for care now? Start with what the law allows where you live, then how a legitimate prescription works.

Run a pharmacy, clinic, or telehealth service? Apply for a listing.

Peptide access rules in Wyoming

Yes. A Wyoming resident can obtain FDA approved peptides such as semaglutide and tirzepatide from a Wyoming-licensed physician, including by telemedicine, which Wyoming Statutes section 33-26-102(a)(xxix) defines as the practice of medicine and which the Wyoming Board of Medicine regulates under section 33-26-202. A compounded peptide is available when it is eligible under federal 503A rules and dispensed by a pharmacy licensed by the Wyoming State Board of Pharmacy; out-of-state pharmacies need a Wyoming nonresident pharmacy license under section 33-24-152. Wyoming has no state bulks list, so peptide compounding eligibility follows the FDA framework. [1] [2] [3] [4] [5] [6] [7] [8] [9]

Compounded GLP-1 access in Wyoming

Because rural Wyoming patients often rely on mail order, the practical check is that the shipping pharmacy holds a Wyoming nonresident pharmacy license under section 33-24-152. [1] [8] [10]

Research use only sellers in Wyoming

The Wyoming Pharmacy Act (title 33, chapter 24) limits dispensing of prescription drugs to licensed pharmacies, including licensed nonresident pharmacies, so a seller shipping "research use only" injectable peptides to Wyoming consumers is outside the licensed channel. [7] [11]

How to check a clinic in Wyoming

  1. Confirm the prescribing clinician's license with the Wyoming medical or nursing board.
  2. Ask which pharmacy compounds or dispenses the peptide and check it in the Wyoming State Board of Pharmacy license lookup. [1] [2] [5] [6] [7] [8] [9]
  3. Confirm the peptide can be lawfully compounded: check its status on the regulatory tracker or its peptide page before paying.
  4. Walk away from any seller that labels a peptide "research use only" or "not for human consumption". See the research use only section above for what that means in Wyoming. [7] [11]

Common questions in Wyoming

Can I get a GLP-1 prescription in Wyoming through telemedicine?

Yes. Wyoming treats telemedicine as the practice of medicine under section 33-26-102, so a Wyoming-licensed physician can evaluate you and prescribe remotely, subject to Board of Medicine rules. Wyoming law does not settle whether the visit must be live: no statute or Board of Medicine rule mentions store-and-forward, real-time visits, or questionnaires. [3] [4] [7]

Does an out-of-state telehealth doctor need a Wyoming license?

Generally yes. The Board of Medicine's rules treat telemedicine into Wyoming as requiring a Wyoming license unless an exemption applies. The rules allow narrow exceptions, such as consultation with a Wyoming-licensed physician and limited continuation of an existing relationship, but a new GLP-1 patient should expect a Wyoming-licensed prescriber. [3] [4] [7]

All peptide legal questions for Wyoming

Sources

  1. [1]Wyoming State Board of Pharmacy
  2. [2]Wyoming State Board of Pharmacy: laws and rules
  3. [3]Wyoming Board of Medicine
  4. [4]Wyoming Board of Medicine: rules and regulations (chapter 1, section 7, Exemption from licensure)
  5. [5]Wyoming State Board of Pharmacy rules, chapter 22, Compounding (effective August 19, 2025)
  6. [6]Wyoming State Board of Pharmacy: chapter 22 Compounding, notice and text of proposed 2026 revisions
  7. [7]Wyoming Statutes title 33, Professions and occupations (including 33-26-102(a)(xxix) telemedicine definition, 33-26-202 board powers, and chapter 24 Pharmacy Act)
  8. [8]Wyoming Statutes section 33-24-152, Nonresident pharmacy registration and licensure
  9. [9]FDA: Section 503A of the Federal Food, Drug, and Cosmetic ActFDA
  10. [10]FDA: concerns with unapproved GLP-1 drugs used for weight loss, including shortage resolution and compounding grace periodsFDA
  11. [11]21 U.S.C. 331, Prohibited acts